BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1380429)

  • 21. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
    Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy.
    Herrstedt J; Sigsgaard TC; Nielsen HA; Handberg J; Langer SW; Ottesen S; Dombernowsky P
    Support Care Cancer; 2007 Apr; 15(4):417-26. PubMed ID: 17093916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tropisetron for the prevention of nausea and vomiting during chemotherapy: multicenter clinical study].
    Gutiérrez J; Bronfman L; Cao C; Vásquez A; Derio L; Rosas J; del Castillo C; Yáñez M; Fodor M; Gallardo J; Cerda B; Torres R; Orlandi L; Orlandi F; Kleinman S; Vogel C
    Rev Med Chil; 1996 Aug; 124(8):967-74. PubMed ID: 9196997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy.
    Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
    Med Pediatr Oncol; 1995 Dec; 25(6):457-62. PubMed ID: 7565308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation.
    Or R; Drakos P; Nagler A; Naparstek E; Kapelushnik J; Cass Y
    Support Care Cancer; 1994 Jul; 2(4):245-8. PubMed ID: 8087443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicin.
    Nicolaides C; Giannakakis T; Skarlos D; Athanassiadis A; Fountzilas G; Damigos D; Pavlidis N
    J Exp Clin Cancer Res; 1998 Mar; 17(1):71-5. PubMed ID: 9646236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
    Bleiberg H; Hulstaert F; Buyse M; De Keyser P
    Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current issues in the management of nausea and vomiting.
    Gralla RJ
    Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban Group.
    Van Belle SJ; Cocquyt VF; Bleiberg H; Canon JL; Buyse M; Hulstaert F; De Witte M; De Keyser P; Westelinck K
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():22-30. PubMed ID: 7749166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy.
    Sorbe B; Högberg T; Himmelmann A; Schmidt M; Räisänen I; Stockmeyer M; de Bruijn KM
    Eur J Cancer; 1994; 30A(5):629-34. PubMed ID: 8080678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis: a pilot study with ACTH-Depot plus tropisetron.
    Santini D; Vincenzi B; Fossati C; D'Angelillo RM; Patti G; Bianco V; Avvisati G; Tonini G
    Med Oncol; 2001; 18(2):131-5. PubMed ID: 11778758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
    Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
    Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea.
    Drechsler S; Bruntsch U; Eggert J; Grote-Kiehn J; Gosse H; Bangerter M; Ukena D; Oehm C; Mezger J; Faerber L; Imhoff W; Untch M; Gallmeier WM
    Support Care Cancer; 1997 Sep; 5(5):387-95. PubMed ID: 9322351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, multicentre study comparing daily 2 and 5 mg of tropisetron for the control of nausea and vomiting induced by low-dose cisplatin- or non-cisplatin-containing chemotherapy.
    Wymenga AN; van der Graaf WT; Wils JA; Siegenbeek van Heukelom L; van der Linden GH; Dullemond-Westland AC; Nooy M; van der Heul C; de Bruijn KM; de Vries EG
    Ann Oncol; 1996 Jul; 7(5):505-10. PubMed ID: 8839906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe B; Hallén C; Frankendal B
    Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compassionate use of tropisetron in patients at high risk of severe emesis.
    Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
    Ann Oncol; 1993; 4 Suppl 3():43-5. PubMed ID: 8364000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of tropisetron in the prevention of cisplatin-induced nausea and vomiting in advanced non-small cell lung cancer.
    Thongprasert S
    Acta Oncol; 2000; 39(2):221-4. PubMed ID: 10859015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.